BDMD
Baird Medical Investment Holdings Ltd.
NASDAQ · Healthcare · Medical - Devices · CN
$1.09
−6.84%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 56.4M | 22.5M | 37.0M | 31.5M | 35.1M |
| Cost of Revenue | 7.7M | 3.7M | 4.4M | 4.2M | 7.1M |
| Gross Profit | 48.7M | 18.9M | 32.7M | 27.2M | 28.0M |
| Operating Expenses | |||||
| R&D Expense | 24.3M | 20.1M | 6.2M | 4.3M | 3.9M |
| SG&A Expense | 37.6M | 24.4M | 10.0M | 11.1M | 10.5M |
| General & Admin Expense | 12.6M | 14.1M | 5.9M | 8.5M | 7.0M |
| Selling & Marketing Expense | 4.0M | 10.3M | 4.1M | 2.5M | 3.6M |
| Other Expenses | 1.4M | (93.4K) | 1.2M | — | — |
| Total Operating Expenses | 63.2M | 44.4M | 17.3M | 15.4M | 13.0M |
| Cost and Expenses | 70.9M | 48.1M | 21.7M | 19.6M | 20.1M |
| Operating Income (EBIT) | (14.6M) | (25.5M) | 15.3M | 11.9M | 13.6M |
| Non-Operating | |||||
| Interest Income | 762.00 | — | 393.00 | — | 8.6K |
| Interest Expense | 1.4M | 737.4K | 576.8K | 284.3K | 299.3K |
| Net Interest Income | (1.4M) | (737.4K) | (576.4K) | (284.3K) | (290.7K) |
| Other Non-Op Income/Expense | (2.0M) | (837.6K) | (1.2M) | 497.5K | 890.2K |
| Non-Operating Income (excl Interest) | (8.6K) | 100.2K | 651.0K | — | (1.2M) |
| EBT (Pre-Tax Income) | (16.6M) | (26.4M) | 14.1M | 12.4M | 14.5M |
| Income Tax Expense | 2.7M | 1.2M | 1.5M | 1.7M | 1.7M |
| Bottom Line | |||||
| Net Income | (19.1M) | (27.3M) | 12.5M | 10.5M | 12.6M |
| Earnings from Cont. Ops | (19.3M) | (27.5M) | 12.6M | 10.7M | 12.8M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (19.1M) | (27.3M) | 12.5M | 10.5M | 12.6M |
| Per Share | |||||
| Basic EPS | ($0.60) | ($0.98) | $0.49 | $0.41 | $0.02 |
| Diluted EPS | ($0.60) | ($0.98) | $0.49 | $0.41 | $0.02 |
| Revenue Per Share | $1.38 | $0.81 | $1.45 | $4.15 | $5.58 |
| Shares | |||||
| Basic Shares Outstanding | 41.0M | 27.8M | 25.6M | 7.6M | 6.3M |
| Diluted Shares Outstanding | 41.0M | 27.8M | 25.6M | 7.6M | 7.2M |
| Profitability Metrics | |||||
| EBITDA | (12.6M) | (24.5M) | 16.2M | 12.9M | 16.3M |
| D&A | 2.0M | 1.1M | 1.5M | 1.0M | 1.5M |
| EBIT | (14.5M) | (25.6M) | 14.7M | 11.9M | 14.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026